Harvard Bioscience, Inc. (HBIO)
7.55
+0.07
(+0.94%)
USD |
NASDAQ |
Aug 24, 16:00
7.34
-0.21
(-2.78%)
After-Hours: 20:00
Harvard Bioscience Total Liabilities (Quarterly) : 68.87M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 68.87M |
| March 31, 2026 | 67.89M |
| December 31, 2025 | 66.34M |
| September 30, 2025 | 63.92M |
| June 30, 2025 | 64.36M |
| March 31, 2025 | 64.97M |
| December 31, 2024 | 63.30M |
| September 30, 2024 | 65.92M |
| June 30, 2024 | 61.66M |
| March 31, 2024 | 64.35M |
| December 31, 2023 | 64.29M |
| September 30, 2023 | 65.45M |
| June 30, 2023 | 67.51M |
| March 31, 2023 | 71.24M |
| December 31, 2022 | 73.14M |
| September 30, 2022 | 75.03M |
| June 30, 2022 | 77.77M |
| March 31, 2022 | 81.67M |
| December 31, 2021 | 78.94M |
| September 30, 2021 | 76.98M |
| June 30, 2021 | 75.27M |
| March 31, 2021 | 74.13M |
| December 31, 2020 | 79.57M |
| September 30, 2020 | 72.45M |
| June 30, 2020 | 74.62M |
| Date | Value |
|---|---|
| March 31, 2020 | 80.25M |
| December 31, 2019 | 83.18M |
| September 30, 2019 | 85.67M |
| June 30, 2019 | 85.91M |
| March 31, 2019 | 90.99M |
| December 31, 2018 | 85.89M |
| September 30, 2018 | 84.08M |
| June 30, 2018 | 88.04M |
| March 31, 2018 | 91.65M |
| December 31, 2017 | 28.45M |
| September 30, 2017 | 33.77M |
| June 30, 2017 | 33.65M |
| March 31, 2017 | 34.68M |
| December 31, 2016 | 35.57M |
| September 30, 2016 | 36.28M |
| June 30, 2016 | 37.42M |
| March 31, 2016 | 39.68M |
| December 31, 2015 | 42.62M |
| September 30, 2015 | 39.27M |
| June 30, 2015 | 43.76M |
| March 31, 2015 | 43.62M |
| December 31, 2014 | 40.45M |
| September 30, 2014 | 39.35M |
| June 30, 2014 | 39.48M |
| March 31, 2014 | 39.11M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 5.943B |
| Bio-Rad Laboratories, Inc. | 3.078B |
| Bruker Corp. | 3.617B |
| Danaher Corp. | 39.78B |
| Illumina, Inc. | 3.812B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 76.29M |
| Shareholders Equity (Quarterly) | 7.418M |
| Debt to Equity Ratio | 5.959 |
| Current Ratio | 1.874 |
| Net Debt Paydown Yield | 0.29% |